Scientific Resources

Meetings & Programs Across the Field

Please note, the ISSCR is not responsible for events listed, but provides them as a service to the field.

Have a suggestion for events, conferences, workshops, and training from the stem cell and regenerative medicine community we should feature? Fill out the form below to have the event considered.

Global Directory of Societies & Networks

Asia Pacific

Europe

Middle East

North America

South America

To add your organization to this directory, contact us here.

Cell Stem Cell

Cell Stem Cell is an affiliate journal of the ISSCR. It is a broad-spectrum journal that covers the entire spectrum of stem cell biology. Topics covered include pluripotency and reprogramming, tissue-specific stem cells, differentiation, genomics and systems biology, stem cell niches, disease models, and clinical and translational insights.

Upcoming Funding Opportunities

  • Amnion Foundation Seed Grant Program

    Description: The Amnion Foundation is a registered 501(c)3 organization specializing in the repurposing of otherwise discarded birth tissues (placenta and umbilical cord) for the generation of primary human cells to support advancements in regenerative medicine and drug discovery. Available cell types include umbilical vein-derived endothelial cells, placental tissue-derived endothelial cells, cytotrophoblasts, macrophages, classical umbilical cord-derived MSC, and pericyte-like placental stem/stromal cells.

    Deadline: TBD

    Funding Amount: Primary cells and supporting reagents valued at up to $10,000 USD; Technical support will also be provided to the recipients for their selected cell type(s).

    Website: Learn more here.

  • CIRM Clinical Trial (CLIN2) Awards

    Description: CIRM’s CLIN2 funding program will support the completion of phase 1, 2, or 3 clinical trials— including pivotal trials— for regenerative medicine therapies that address significant unmet medical needs and have the potential to provide transformative benefits to patients, their families, and the healthcare system. Through this program, CIRM creates funding opportunities for regenerative medicine clinical research that otherwise do not exist or are of limited scope. CIRM will devote internal resources and leverage a network of world-class subject matter experts to help ensure that funded projects have a comprehensive clinical development strategy aimed at obtaining marketing approval with a well-developed plan for ensuring patient access.

    Deadline: 23 October 2026

    Funding Amount: The award amount ranges from $8 million to $15 million and is dependent on the stage of the clinical trial and the for-profit versus non-profit status of the applicant organization. Projects may have a maximum planned duration of four years.

    Website: Learn more here.

  • Open

    To post an upcoming funding opportunity, please contact us here.

Organizations with Recurring Funding Opportunities